search
Back to results

Ischemic Pain Control With Analgesic Methods Clinical Trial (ISCHAEMIC)

Primary Purpose

Arterial Occlusive Diseases

Status
Unknown status
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Continuous peripheral sciatic nerve block
Fentanyl
Ropivacaine
Perineural catheter
Sponsored by
University of Sao Paulo General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Arterial Occlusive Diseases

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients older than 18 years old who have strong or moderate persistent ischemic pain in the lower limbs, due to peripheral artery occlusive disease, classified as Fontaine IV (pain at rest and presence of ulcer or gangrene).

Exclusion Criteria:

  • Uncooperative patients, coagulation disorders, patients with liver failure, who have atrioventricular block second or third degree, who refuse to be submitted to peripheral nerve block, with systemic or procedure site local infection infection, peripheral or central neuropathy history, allergies to local anesthetics or to any of the drugs to be used in the study and difficulty in understanding the use of the PCA (patient-controlled analgesia) device and evaluation methods used in the study .

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Continuous nerve block

    Systemic analgesia

    Arm Description

    Continuous peripheral sciatic nerve block through popliteal perineural catheter with ropivacaine

    Intravenous fentanyl patient controlled analgesia device

    Outcomes

    Primary Outcome Measures

    Pain intensity
    Verbal numerical scale

    Secondary Outcome Measures

    Opioids Adverse effects
    Nausea, vomiting, constipation, sedation

    Full Information

    First Posted
    July 17, 2016
    Last Updated
    July 21, 2016
    Sponsor
    University of Sao Paulo General Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02841488
    Brief Title
    Ischemic Pain Control With Analgesic Methods Clinical Trial
    Acronym
    ISCHAEMIC
    Official Title
    Comparative Study Between Systemic Analgesia and Continuous Sciatic Nerve Block in Patients With Chronic Obstructive Arterial Disease and Ischemic Pain in Lower Limbs
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 2016 (undefined)
    Primary Completion Date
    September 2018 (Anticipated)
    Study Completion Date
    October 2018 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Sao Paulo General Hospital

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This project is one of four components of a thematic project that aims to evaluate the use of ultrasound in regional blocks, called "Use of ultrasound in regional blocks and injections for the treatment of acute and chronic pain." It will evaluate quantitative and qualitative control of ischemic pain in the lower limbs in patients with peripheral arterial occlusive disease through continuous sciatic nerve block by perineural catheter, popliteal approach, compared to systemic analgesia based on opioids.
    Detailed Description
    BACKGROUND: Peripheral arterial occlusive disease (PAOD) commonly evolves with intense ischemic pain in the lower limbs, which is hard to control with systemic analgesics, and continuous regional anesthesia may be an alternative, with adequate analgesia and lower incidence of side effects. OBJECTIVES: evaluate qualitative and quantitative pain control, incidence of adverse effects and operative results in patients with PAOD undergoing continuous anesthetic blockade of the sciatic nerve by perineural catheter compared to systemic analgesia based on opioids and adjuvant medications. METHODS: It is a randomized clinical trial, covered for evaluators. It will include 56 patients with PAOD Fontaine IV, with pain by the presence of ulcerations located on foot. A group will be submitted to continuous regional anesthesia of sciatic nerve through perineural catheter and another group will have its pain control through patient controlled analgesia device with intravenous fentanyl. The primary dependent variable will be pain, through the numerical pain scale.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Arterial Occlusive Diseases

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    56 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Continuous nerve block
    Arm Type
    Active Comparator
    Arm Description
    Continuous peripheral sciatic nerve block through popliteal perineural catheter with ropivacaine
    Arm Title
    Systemic analgesia
    Arm Type
    Active Comparator
    Arm Description
    Intravenous fentanyl patient controlled analgesia device
    Intervention Type
    Procedure
    Intervention Name(s)
    Continuous peripheral sciatic nerve block
    Other Intervention Name(s)
    Perineural sciatic catheter
    Intervention Description
    Continuous infusion of local anesthetics through perineural sciatic nerve catheter
    Intervention Type
    Drug
    Intervention Name(s)
    Fentanyl
    Other Intervention Name(s)
    Intravenous fentanyl
    Intervention Description
    Use of patient controlled analgesia device with intravenous fentanyl
    Intervention Type
    Drug
    Intervention Name(s)
    Ropivacaine
    Intervention Type
    Device
    Intervention Name(s)
    Perineural catheter
    Primary Outcome Measure Information:
    Title
    Pain intensity
    Description
    Verbal numerical scale
    Time Frame
    up to 28th day
    Secondary Outcome Measure Information:
    Title
    Opioids Adverse effects
    Description
    Nausea, vomiting, constipation, sedation
    Time Frame
    up to 28th day

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients older than 18 years old who have strong or moderate persistent ischemic pain in the lower limbs, due to peripheral artery occlusive disease, classified as Fontaine IV (pain at rest and presence of ulcer or gangrene). Exclusion Criteria: Uncooperative patients, coagulation disorders, patients with liver failure, who have atrioventricular block second or third degree, who refuse to be submitted to peripheral nerve block, with systemic or procedure site local infection infection, peripheral or central neuropathy history, allergies to local anesthetics or to any of the drugs to be used in the study and difficulty in understanding the use of the PCA (patient-controlled analgesia) device and evaluation methods used in the study .
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Hermann S Fernandes, MD
    Phone
    +55 84 988966348
    Email
    hermann.fernandes@hc.fm.usp.br
    First Name & Middle Initial & Last Name or Official Title & Degree
    Hazem A Ashmawi, PhD
    Phone
    +55 11 985733798
    Email
    hazem.ashmawi@hc.fm.usp.br
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Joaquim E Vieira, PhD
    Organizational Affiliation
    Professor
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided
    Citations:
    PubMed Identifier
    15262830
    Citation
    Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004 Aug 10;110(6):738-43. doi: 10.1161/01.CIR.0000137913.26087.F0. Epub 2004 Jul 19.
    Results Reference
    background
    PubMed Identifier
    15184277
    Citation
    Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation. 2004 Jun 29;109(25):3196-201. doi: 10.1161/01.CIR.0000130848.18636.B2. Epub 2004 Jun 7.
    Results Reference
    background
    PubMed Identifier
    12719196
    Citation
    Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR 3rd, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA; Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003 Apr 28;163(8):884-92. doi: 10.1001/archinte.163.8.884. No abstract available.
    Results Reference
    background
    PubMed Identifier
    2673321
    Citation
    McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989 Jul;3(3):273-7. doi: 10.1016/S0890-5096(07)60040-5. No abstract available.
    Results Reference
    background
    PubMed Identifier
    9844701
    Citation
    Marquis P, Lecasble M, Passa P. [Quality of life of patient with peripheral arterial obliterative disease treated with ifenprodil tartrate. Results of an ARTEMIS study]. Drugs. 1998;56 Suppl 3:37-48. doi: 10.2165/00003495-199856003-00005. French.
    Results Reference
    background
    PubMed Identifier
    11068220
    Citation
    Campbell WB, Marriott S, Eve R, Mapson E, Sexton S, Thompson JF. Anaesthesia and analgesia for major lower limb amputation. Cardiovasc Surg. 2000 Dec;8(7):572-5. doi: 10.1016/s0967-2109(00)00071-5.
    Results Reference
    background
    PubMed Identifier
    21821511
    Citation
    Ilfeld BM. Continuous peripheral nerve blocks: a review of the published evidence. Anesth Analg. 2011 Oct;113(4):904-25. doi: 10.1213/ANE.0b013e3182285e01. Epub 2011 Aug 4.
    Results Reference
    background
    PubMed Identifier
    18784489
    Citation
    Capdevila X, Ponrouch M, Choquet O. Continuous peripheral nerve blocks in clinical practice. Curr Opin Anaesthesiol. 2008 Oct;21(5):619-23. doi: 10.1097/ACO.0b013e32830c66c2.
    Results Reference
    background
    Available IPD and Supporting Information:
    Available IPD/Information Type
    Informed Consent Form
    Available IPD/Information URL
    http://aplicacao.saude.gov.br/plataformabrasil/visao/pesquisador/gerirPesquisa/gerirPesquisaAgrupador.jsf

    Learn more about this trial

    Ischemic Pain Control With Analgesic Methods Clinical Trial

    We'll reach out to this number within 24 hrs